Steroid profiling helps various pathologies to be rapidly diagnosed. Results from analyses investigating steroidogenic pathways may be used as a tool for uncovering pathology causations and proposals of new therapeutic approaches. The purpose of this study was to address still underutilized application of the advanced GC-MS/MS platform for the multicomponent quantification of endogenous steroids. We developed and validated a GC-MS/MS method for the quantification of 58 unconjugated steroids and 42 polar conjugates of steroids (after hydrolysis) in human blood. The present method was validated not only for blood of men and nonpregnant women but also for blood of pregnant women and for mixed umbilical cord blood. The spectrum of analytes includes common hormones operating via nuclear receptors as well as other bioactive substances like immunomodulatory and neuroactive steroids. Our present results are comparable with those from our previously published GC-MS method as well as the results of others. The present method was extended for corticoids and 17α-hydroxylated 5α/β-reduced pregnanes, which are useful for the investigation of alternative "backdoor" pathway. When comparing the analytical characteristics of the present and previous method, the first exhibit by far higher selectivity, and generally higher sensitivity and better precision particularly for 17α-hydroxysteroids.
Introduction
For almost six decades, gas chromatography-mass spectrometry (GC-MS) served as an efficient tool for the routine quantification of endogenous steroids (Hill et al. 2010a , Hill et al. 2010b , Krone et al. 2010 ). At present, liquid chromatography-tandem mass spectrometry (LC-MS/MS) is also widely used and has become the gold standard for steroid quantification (Soldin and Soldin 2009) . A number of LC-MS/MS based steroidomics studies was primarily focused on corticosteroids and their metabolites (Gomes et al. 2009 , Haneef et al. 2013 , Marcos et al. 2014 ). Other chromatographic strategies may involve a direct LC-MS/MS detection of unaltered glucuronoconjugated metabolites (Esquivel et al. 2017) or the use of supercritical fluids for extraction of steroidome (Kureckova et al. 2002) . However, in steroid metabolomics (steroidomics), GC-MS remains the method of choice (Krone et al. 2010) . A more advanced and therefore more sensitive, specific and precise GC-MS platform known as gas-chromatography tandem-mass spectrometry (GC-MS/MS) has lately been developed. The GC-MS/MS platform on the one hand retains the advantages of GC-MS in precisely distinguishing isomers with the same mass to charge ratio (m/z). However, the use of GC-MS/MS in the analysis of endogenous steroids has still been limited. Current studies using the GC-MS/MS platform have mostly focused on the quantification of anabolic steroids in the blood of athletes or farmyard animals (Gambelunghe et al. 2007 , Impens et al. 2007 , Marcos et al. 2002 , Raro et al. 2016 , Rossi et al. 1994 , Shen et al. 2008 , Van Vyncht et al. 1994 , Wong et al. 2016 , Yamada et al. 2008 or on steroid quantifications in wastewaters (Andrasi et al. 2013 , Kelly 2000 , Trinh et al. 2011 , Zuehlke et al. 2005 . Bloklanda et al. (Blokland et al. 2012 ) simultaneously quantified 47 steroids in the form of unconjugated steroids, glucuronides and sulfates in bovine urine. Regarding the number of steroids detected, the lead is still held by a series of studies from Christakoudi et al. who identified and quantified human urinary steroids. Their first study included 146 C21 steroids (Christakoudi et al. 2010) , the second one 32 additional C21 steroids (Christakoudi et al. 2012a) , the third 76 C19 steroids (Christakoudi et al. 2012b ) and the fourth study additional 52 C21 steroids (Christakoudi et al. 2013 ). These studies have provided a complex qualitative picture of the urinary steroid metabolome in humans; however, the lack of validation of the methods used remains its weakness. The authors from research group headed by Man-Ho Choi (Molecular Recognition Research Center of Korea Institute of Science and Technology) published a series of extensive metabolomic studies on the GC-MS platform, which were focused on the role of urinary steroids in human physiology and pathophysiology (Ha et al. 2009 , Choi and Chung 2014 , Kim et al. 2013 , Moon et al. 2016 ). There are few GC-MS/MS studies focused on circulating steroids in humans and other mammals, and all have quantified a limited number of steroids (Courant et al. 2010 , Hansen et al. 2011 , Matysik and Schmitz 2015 , Nilsson et al. 2015 , Styrishave et al. 2017 ).
The purpose of this study was to address the application of the GC-MS/MS platform for the simultaneous quantification of endogenous steroids. We developed and validated a GC-MS/MS method for the multicomponent quantification of unconjugated steroids and their polar conjugates (after hydrolysis). Of the original 120 steroids or their polar conjugates tested, only 100 of them met validation criteria for at least some physiological situations. Our method was validated not only for blood of men and non-pregnant women but also for blood of pregnant women and for umbilical cord blood. The spectrum of analytes in our method includes precursor steroids, active steroids and steroid metabolites, and covers the vast part of steroid metabolome in humans (see Figures 1 and 2 ). Steroid profiling helps various pathologies to be rapidly diagnosed. Moreover, the results from analyses investigating steroidogenic pathways may be used as a tool for uncovering pathology causations and proposals of new therapeutic approaches (Bicikova et al. 2013 , Hill et al. 2010c , Kanceva et al. 2015 , Parizek et al. 2016 , Sosvorova et al. 2015 , Sterzl et al. 2017 , Vankova et al. 2016 . 
Experimental

Samples
Serum samples from non-pregnant subjects were collected from the employees of the Institute of Endocrinology, Prague, Czech Republic and their relatives, as well as from patients of the Institute of Endocrinology. Serum samples from pregnant women and umbilical cord serum at birth were obtained from patients of the Department of Gynecology and Obstetrics, General University Hospital and 1 st Faculty of Medicine of Charles University in Prague. For all participants, the clinical protocol was approved by the Ethics Committee of the Institute of Endocrinology and by the Ethics Committee of the General University Hospital and 1 st Faculty of Medicine of Charles University in Prague. Informed written consent was obtained from all participants. Serum from blood was obtained after centrifugation (5 min at 2000 × g at 2°C), and stored at −20°C until analyzed.
Chemicals
Most steroids and deuterated standards were purchased from Steraloids (Newport, RI, USA). The deuterated standard D7 cortisone [2,2,4,6,6,12,12-D7] and trimethylchlorosilane (TMCS) for hydrolysis of steroids conjugates were from Sigma-Aldrich (St. Louis, USA). Sylon BTZ, methoxyamine hydrochloride and all other solvents and chemicals were from Merck (Darmstadt, Germany). All solvents were of HPLC grade.
Stock solutions, calibration standards, and quality control samples
Stock solutions of external and internal standards (ISs) were prepared in methanol at the concentration of 1 mg/mL. The calibration curve samples (charcoal-stripped plasma with internal and external standards) were prepared in triplicate, blank samples (charcoal-stripped plasma without ISs) were made separately for unconjugated and conjugated steroids as well as zero samples (charcoal-stripped serum with ISs) were prepared. Charcoal-stripped serum was made using a multistep adsorption of steroids on charcoal. The absence of steroids in this matrix was checked by spiking of serum with [ 3 H]cortisol (10,000 dpm/mL) and measurement of the residual radioactivity close to zero. In brief, 100 g of Activated Charcoal Norit from Sigma-Aldrich (St. Louis, USA) was mixed with 1 liter of deionized water and let overnight. Then the water with fine particles of the charcoal was decanted, the charcoal was spread out on the filtration paper and let overnight. Then the charcoal was dried at 200°C in glass baking bowl for 2 hours. The dried charcoal was stored in wide mouth glass reagent bottle. Afterwards, 10 7 dpm of 3H cortisol from NEN® Life Science Products (Boston, MA, USA) was added to 1 liter of pooled human serum and 200 μL of the mixture was measured in triplicate in scintillation counter (1000 -2000 dpm). Than the charcoal (50 g) was mixed with the pooled serum at 4°C for 3 hours. Then the centrifugation in cooled centrifuge followed at 4°C for 20 min (3500 rpm). Subsequently, the supernatant was decanted and filtered across the folded filter paper in refrigerator and the filtrate is then mixed with further 50 g of the charcoal overnight in the refrigerator and afterwards the further filtration followed. The filtrate was then treated (in parts) at 84000 g in ultracentrifuge at 4°C for 25 min and the centrifugation was repeated until the serum was free of charcoal particles. Finally, the 200 μL of the treated serum was measured (in triplicate) for 3H radioactivity together with the 200 μL of water (in triplicate) as negative control and the results were compared with initial activity of the 3H cortisol spiked serum.
Quality control (QC) samples were prepared using different serum pools from adult men, women in follicular menstrual phase and women in luteal menstrual phase, pregnant women (week 28-42 of pregnancy) and from mixed umbilical cord serum, which was collected at labor (week 28-42 of pregnancy). Using five pools differing according to gender, menstrual phase, pregnancy status and matrix (mixed umbilical serum) the QC control samples contained substantially different steroid levels covering gender differences and distinct physiological status in women. The number of samples in mixed pools in individual groups out of pregnancy was greater than 100 for each group, while the sample numbers for the groups of pregnant women and mixed umbilical serum were greater than 30 for each group.
From each stock solution of steroid (1 mg/mL), 10 μL was added into the glass tube. The mixture was dried in vacuum centrifuge (2 hours). Then the stock solution for calibration samples were prepared in concentrations 5000, 1000, 250, 62.5, 15.625, 3.906, 0.977, 0.244, 0 .061 ng/mL in methanol. From these stock solutions 100 μL was administered to 10 mL extraction glass tubes vials and the mixtures were dried in the vacuum centrifuge at 45°C. Then 1 mL of charcoal-stripped serum and the solutions were mixed for 1 min. The next steps were identical for the calibration samples, zero samples, quality control samples and serum samples. The amount of 15 μL from the mixed stock solution containing ISs was added to the aforementioned samples. The mixed stock solution of ISs for quantification of unconjugated steroids was prepared from the stock solutions of individual ISs as follows: 10 μL D6-dehydroepiandrosterone (D6-DHEA) ([2,2,3,4,4,6 -D6]-DHEA, 1 mg/mL), 10 μL D8-Prog17 ([2,2,4,6,6,21,21,21 -D8]-17α-hydroxyprogesterone 1 mg/mL), 10 μL D9-Prog ([2,2,4,6,6,17α,21,21,21 -D9]-progesterone, 1 mg/mL), 100 μL D4-cortisol ([9,11,12 ,12-D4)-cortisol, 1 mg/mL), 50 μL D7-cortisone ([2,2,4,6,6,12,12 -D7]-cortisone, 10 μg/mL) were mixed, the mixture was dried under the flow of nitrogen and the dry residue was dissolved in 1 mL of methanol. The internal standard of D6-DHEA sulfate ([2,2,3,4,4,6-D6] -DHEA sulfate, 1 mg/mL) for quantification of conjugated steroids was prepared similarly. The volume of 50 μL D6-DHEA sulfate, 1 mg/mL) was dried under the flow of nitrogen and the dry residue was dissolved in 1 mL of methanol.
Sample preparation
The sample preparation proceeded as follows: after addition of 15 μL of the mixed stock solution of ISs for quantification of unconjugated steroids to 1 mL of serum fluid and mixing (1 min), the unconjugated steroids were extracted from 1 mL of the mixture with diethyl-ether (3 mL). The diethyl-ether extract was dried in a block heater at 37°C. The lipids in the dry residue of the diethyl-ether extract were separated by partitioning between a mixture of methanol with water 4:1 (1 mL) and pentane (1 mL). The pentane phase was discarded and the polar phase was dried in a vacuum centrifuge at 60°C (2 h). The dry residue from the polar phase was firstly dissolved in 100 μL of acetonitrile. The solution was transferred into the 1 mL conical vial and dried in the flow of nitrogen. The dry residue was derivatized first with a methoxyamine hydrochloride solution in pyridine (2%) (60°C, 1 h) to convert the oxo-groups to methyloxime derivatives. After this first derivatization, the mixture was dried in a flow of nitrogen and the dry residue was treated with the reagent Sylon BTZ (90°C, 24 h. The Sylon BTZ is a mixture of N,O-bis(trimethylsilyl)acetamide (BSA) + trimethylchlorosilane (TMCS) + N-trimethylsilylimidazole (TMSI) (3:2:3). This sylilating agent forms trimethylsilyl derivatives on hydroxy-groups (TMS-MOX derivatives). After this second derivatization step, the mixture was dried in the nitrogen flow (2 min). After administration of approximately 1 mg of ammonium bicarbonate, the residue was partitioned between isooctane (100 μL) and N,Ndimethylformamide (50 μL). Then the volume of the vial was mixed (1 min) and centrifuged for 20 min at 3000 rpm. The lower, polar layer was aspirated with a Pasteur pipette and the upper non-polar layer remained in the vial for GC-MS/MS analysis. From the upper layer, 2 μL was injected into the GC-MS/MS system. Steroid conjugates remaining in the polar residue after diethyl ether extraction were analyzed as follows: The volume of 15 μL D6-DHEA sulfate solution (50 μg/mL) was mixed with this residue (1 min mixing). Then 1 mL of methanol was added and mixed for additional 1 min. After the centrifugation of the mixture (20 min at 3000 rpm), the upper layer was transferred to the clean 10 mL extraction tube, dried in the vacuum centrifuge at 37°C (5 h), and the dry residues were chemically hydrolyzed according to Dehennin (Dehennin and Peres 1996) . Briefly, 1mL of 1M TMCS was added to the dry residue of the upper layer and after 1 min mixing, the hydrolysis proceeded for 1 hour at 55°C. Then 100 mg of sodium bicarbonate was added and after short mixing, the hydrolyzed samples were again dried in the vacuum centrifuge at 37°C (5 h). The dried residues were reconstituted with 500 μL of chromatographic water and then further processed in the same way as the free steroids. The calibration samples for the conjugated steroids were prepared similarly as for their unconjugated analogues but the standards were mixed with the polar residues after diethyl ether extraction instead of the 1 mL of charcoal-stripped serum.
Instruments and chromatography conditions
Instrument settings
The instrument used was a GCMS-TQ8040 system from Shimadzu (Kyoto, Japan) consisting of a gas chromatograph equipped with an automatic flow control, an AOC-20s autosampler and a triple quadrupole detector with an adjustable electron voltage of 10-195 V. The analysis was conducted in multiple reaction monitoring (MRM) mode. A capillary column with a medium polarity RESTEK Rtx-50 column (diameter 0.25mm, length 15 m, film thickness 0.1 μm) was used for analyses. Electron-impact ionization with electron voltage fixed at 60 V and emission current set to 151 μA was used for the measurements. The temperatures of the injection port, ion source and interface were maintained at 220, 300, and 310°C, respectively. Analyses were carried out in the splitless mode with a constant linear velocity of the carrier gas (He), which was maintained at 60 cm/s. The septum purge flow was set to 3 mL/min. The samples were injected using a high-pressure mode, which was applied at 200 kPa and maintained for 1 min. The detector voltage was set to 2.2 kV. The temperature program was as follows: 1 min delay at 80 °C, increase to 190 °C (40 °C/min), increase to 210 °C (6 °C/min), increase to 300 °C (20 °C/min), increase to 320 °C (40 °C/min), 4 min delay at 320 °C, initial pressure 34 kPa, injector temperature 220 °C, analysis duration 16.08 min.
Optimization of method sensitivity
To optimize method sensitivity, the analysis was carried out using two separately injected aliquots (2 μL) for two different groups of steroids for each sample (see Table 1 ). The injection volume of samples was 2 μL. However, two steroid sulfates injected in the second aliquot exceeded the upper limit of linear dynamic range (LDR). To quantify these analytes, this measurement was repeated using the third aliquot with reduced injection volume (0.2 μL). The list of analytes with corresponding abbreviations, correlation coefficients (characterizing the linearity of the response) and the respective LDRs with indication of the abundant steroid conjugates quantified in the third aliquot are shown in Table 2 .
For further improvement of sensitivity, the method used time-programmed MRM acquisition. The number of injection aliquot, number of time-programmed MRM acquisition window (AW), MRM transitions with corresponding optimum collision energies for individual steroids and ISs for the corresponding steroids are shown in Table 1 . The optimization of collision energies for individual steroids was performed using the Microsoft Excel Macro-Enabled Worksheet named "MRM Optimization Tool" from Shimadzu (Kyoto, Japan).
The number of qualifiers ranged from no qualifier to three qualifiers with respect to the fragmentation patterns of individual steroid derivatives and sensitivity of the method, which is inversely related with the number of MRM transitions in the given AW (Table 1 ). For instance, in the case of 21-deoxycortisol (DOF) just a single MRM transition was selected 517>427 (12V) as the quantifier without a qualifier, because only this transition had a satisfactory response ( Table 1 ). The case of PD3β5α20α was similar. In addition, the respective AW 7 included a relatively high number of transitions, which limited the sensitivity. On the other hand, in the AW 1, the androstanediols were measured using three confirmation MRM transitions as the total number of transitions in AW 1 was low (Table 1) .
Selection of internal standards
To represent different chemical and physical properties of various steroid molecules we originally tried to use a maximum number of available ISs. However, we also respected the number of deuterium atoms in the steroid molecule, which is sufficient for separation of the signals from non-deuterated steroid and its deuterated counterpart and, at the same time, wide concentration range of steroids in serum samples, and isotopic purity of the ISs. In addition, we also considered an inverse relationship between the number of MRM-transitions in acquisition windows and sensitivity of the assay. Therefore, from the original number of 16 deuterated steroids we selected five deuterated standards with different polarity such as D6-DHEA sulfate (IS1) D6-DHEA (IS2), D8-Prog17 (IS3), D9-Prog (IS4), D4-cortisol (IS5), and D7-cortisone (IS6). For the conjugated steroids, only IS1 was applicable, because the remaining ISs were instable during the hydrolysis. Therefore, for the quantification of steroid conjugates, the IS1 was used instead of IS3 and IS4 (see Table 1 ).
Independent analytical methods used for accuracy testing
To compare some results of the present method, we measured 47 analytes using our previously published GC-MS method (Hill et al. 2010b) , 6 analytes by our LC-MS/MS method (Vitku et al. 2016 ) and cortisol was also measured by radioimmunoassay from Immunotech (Marseilles, France). 
Calibration curve and linearity of the response
The calibration was performed in charcoal-stripped serum. The analytes were quantified using calibration curves based on known concentrations in the mixtures of analyzed standards with constant level of ISs. We used a 9-point logarithmic calibration curve. The values were corrected for procedural losses according to yields of ISs. The use of ISs for individual steroids is shown in Table 1 . The amount of each steroid injected from the calibration samples into the GC-corresponded to amount of 10 ng, 2 ng, 500 pg, 125 pg, 31.2 pg, 7.81 pg, 1.95 pg, 488 fg and 122 fg. The calibration curves were constructed by plotting the logarithm of response factor (analyte area/internal standard area) against the logarithm of concentration of the calibration (external) standard to cover the large concentration differences for circulating steroids in different physiological and pathophysiological situations and even more explicit contrasts between unconjugated steroids and their conjugated counterparts at appropriate number of calibration points. This arrangement also provided equal weights for individual calibration points in the logarithmic calibration curve and therefore the use of weighted regression model was not necessary to apply. The assay acceptance criterion for each back-calculated standard concentration was set 15% deviation from the nominal value.
Precision
The method precision (intra-assay, within-day) and intermediate precision (inter-assay, between-day) was based on the concentrations of each analyte. Regarding gender differences in the levels of testosterone and its metabolites, elevated levels of progesterone and its metabolites in the luteal menstrual phase and excessive levels of numerous steroids in serum from pregnant women and in umbilical cord serum, the precision was evaluated separately in pooled sera for adult men, women in the follicular menstrual phase, luteal menstrual phase, pregnant women at labor and for mixed umbilical cord sera at labor. The method precision was calculated from steroid concentrations in six identical samples, which were prepared from the aforementioned pools within one batch prepared on the same day. Similarly, intermediate precision was estimated from the steroid concentrations in six identical samples but these were prepared in separate batches on different days. The precision was expressed as percent of relative standard deviation (RSD).
Recovery
The recovery indicates the extraction efficiency of an analytical process, reported as a percentage of the known amount of an analyte carried through the sample extraction and processing steps of the method (2018) . In the present method, the recovery was determined by spiking charcoal-stripped serum with three concentrations of the individual analytes taking into account steroid levels in the corresponding pools. The recovery experiments were performed by comparing the analytical results of extracted samples with corresponding extracts of blanks spiked with the analyte post-extraction (2018) in replicates from four independent runs.
Accuracy
Accuracy was expressed as relative error of the measured concentration of each steroid with respect to its true spiked concentration (% bias). The accuracy testing was performed for three different concentrations of analytes dissolved in charcoal-stripped plasma, which were close to their physiological levels. The bias was tested in both intra-and inter-day experiments. The corresponding samples for accuracy testing were processed in the same way as the calibration and unknown samples (see section 2.4 Sample preparation). The bias less then ±15% was met for all analytes in all tested concentrations in both intra-and inter-day experiments. The analytes, which did not meet these criteria were not included in this method.
Furthermore, we compared our present GC-MS/MS method with our previous GC-MS method for 45 steroids in samples covering all types of human sera (Supplementary Table S1 ) and also tested an agreement of six common steroids (pregnenolone, 17α-hydroxypregenolone, DHEA, androstenedione, testosterone and cortisol) measured by our present method with the LC-MS/MS method (Hill et al. 2010b ) in samples mostly consisting of the women in follicular menstrual phase but there were also some women in the luteal phase, postmenopausal women and men (Supplementary Table S2 ). Besides the LC-MS/MS and GC-MS/MS, the cortisol was also evaluated using an RIA kit from Immunotech (Marseilles, France). The comparison was performed using Bland-Altman procedure (Bland and Altman 1986) and a robust Passing Bablok regression with the use of R library "mcr" (Manuilova and Schuetzenmeister 2014) .
Limit of Detection and Limit of Quantification
Because the baseline noise was accessible for all analytes in all matrixes (pools), the limit of detection (LOD) and limit of quantification (LOQ) were estimated using charcoal stripped plasma spiked with steroids in three levels covering gender differences and distinct physiological status in women. The LOD was calculated as 3.3 times of the baseline noise using charcoal stripped plasma vs. charcoal stripped plasma spiked with steroid on the first level with lowest concentration of analyte.
The lowest nonzero standard on the calibration curve defined the LOQ. The satisfactory analyte response at the LOQ in the present method was at least five times the analyte response of the zero calibrator and the satisfactory bias at the LLOQ was at most ±20% of nominal concentration. Similarly, the satisfactory imprecision at the LLOQ was at most ±20% RSD. For this purpose, we tested the replicates prepared in six runs (2018) . The determination of signal to noise ratios (S/N) for the calculation of LOD was completed using a functionality in the Shimadzu software GCMSsolution Version 4.20, which was a component of our GC-MS/MS system.
Efficiency of methanolysis and stability of non-deuterated and deuterated steroids
Unfortunately, the external standards for steroid sulfates and glucuronides are not available for the full spectrum of the quantified steroid conjugates. Therefore, we have tested the efficiency of methanolysis for only seven sulfated non-deuterated steroids (6 sulfates and one disulfate) and D6-dehydroepiandrosterone sulfate (D6-DHEA). The procedure was as follows. The 100 μL or 10 μL aliquots of the stock solution of unconjugated steroid and sulfated steroid were administered into the glass extraction tubes and dried under the flow of nitrogen. Then 20 μL of methanol was added and the solution was shortly mixed. The addition of 1 mL of charcoal-stripped mixed human plasma followed and the solution was then mixed for 1 min. The obtained samples for each steroid or steroid sulfate were processed in the same way as the calibration and unknown samples (see section 2.4 Sample preparation). The responses (areas under the peak) for polar and non-polar phases after diethyl ether extraction for individual unconjugated steroids, corresponding steroid conjugates and for internal standard (D6-DHEA) were used to calculate extraction efficiency for unconjugated steroids and sulfated steroids, as well as the efficiency of methanolysis in sulfated steroids.
The analysis of chemical stability during the methanolysis for unconjugated steroids was based on the comparison of calibration samples for unconjugated analytes, which were exposed to methanolysis procedure with the same samples, which did not undergo this route.
Terminology of steroid polar conjugates
Concerning the terminology of the steroid polar conjugates used here, the term steroid sulfate was used in the case of the dominance of 3α/β-monosulfate over other forms of steroid conjugates, while the term conjugated steroid was used in the case of comparable amounts of conjugate forms (sulfates, disulfates, and glucuronides). This terminology was based on the relevant literature, with appropriate citations for each steroid as follows: Preg sulfate Belanger 1987, Sanchez-Guijo et al. 2015) , DHPreg20α sulfate, dehydroepiandrosterone (DHEA) sulfate , Labrie et al. 1997 , Sanchez-Guijo et al. 2015 , 5-Adiol sulfate (Labrie et al. 1997 , Sanchez-Guijo et al. 2015 
Results and discussion
In total, the levels of 100 analytes (58 unconjugated steroids and 42 steroid conjugates) were quantified in samples of pooled sera from groups of adult men, women in the follicular menstrual phase, women in the luteal menstrual phase, pregnant women at labor and in umbilical cord serum at labor (see Tables 2 and 4 ). The steroid metabolome in the maternal circulation included the levels of C21 Δ 5 steroids, C19 Δ 5 steroids, C21 Δ 4 steroids, C19 Δ 4 steroids, estrogens, C21 and C19 5α/β-reduced steroids, 7α-hydroxy-, 16α-hydroxy-, 7β-hydroxy-and 7-oxo-derivatives of C19 Δ 5 steroids, and 20α-dihydro-metabolites of C21 steroids (20α-dihydro-pregnanes) (see Table 2 ). Figures 3-6 show a comparison of the chromatograms for calibration samples and samples prepared from five pools of human serum and recorded on quantification MRM transitions for unconjugated steroids, which are less abundant then their conjugated counterparts (Table 3 ). Table 2 . Table 2 . Table 2 . Table 2 .
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Linearity of the response
Sufficient linearity was found for broad range of concentrations (Table 2 ). The 15% deviation from the nominal value for each back-calculated standard concentration as the criterion of assay acceptance was not exceeded in any case.
Precision
As expected, the higher precision was typically obtained for more abundant steroids. For instance, better results were obtained for C19 steroids in non-pregnant subjects but for C21 steroids in pregnant women and in mixed umbilical serum. Higher precision was achieved for more abundant steroid conjugates when compared with their less abundant unconjugated counterparts. The results for T, DHT5α and 5-Adiol were generally better in pooled serum from adult men when compared with other groups. As concerns the accessibility of hydroxy-group for derivatization, the 11β-hydroxy-steroids showed lower precision when compared with their 11-deoxycounterparts due to difficult accessibility of 11β-hydroxy-group for the sylilating agent. If the intra-and/or inter assay exceeded the 15% RSD in some of the tested pooled samples, the validation in this biological material was considered as unsatisfactory. For instance, the levels of several reduced 5β-reduced C21 steroids are insufficient to quantify these analytes out of pregnancy. However, in a nutshell, most analytes may be quantified in all investigated matrixes (Table 3) .
Recovery
In general, the additions of steroids for the computation of recovery were derived from steroid levels in the pooled sample. In two steroid sulfates such as DHEA sulfate and THA3α5αC, the samples for recovery were diluted to be within the LDR (Supplementary Table S3 ). As expected, the recovery rates differed according to the steroid polarity. On the one hand, the diethyl-ether extraction step should be more favorable for the less polar steroids but on the other hand, partitioning between the methanol-water mixture and pentane should be less efficient for the steroids with low polarity. When testing the recovery, we found lower values for less polar steroids such as 5α/β reduced C21 steroids but high values for the polar ones such as cortisol. The number of hydroxy-groups positively correlates with the recovery rate (for instance allopregnanolone vs. 5α-pregnane-3α,20α-diol or allopregnanolone vs. 17-hydroxyallopregnanolone). The 5α/β-reduced steroids showed lower recovery rates in comparison with their unsaturated counterparts (for instance 5α-dihydroprogesterone vs. progesterone or 5α-dihydrotestosterone vs. testosterone). The C19 steroids generally exhibit higher recovery rates in comparison with their C21 analogues (for instance androsterone vs. allopregnanolone).
Accuracy
The accuracy test was not carried out if the If the intra-and/or inter assay for precision exceeded the 15% RSD (see Table 3 ). When the precision testing was acceptable, the bias less then ±15% was met for all analytes in all tested concentrations in both intra-and inter-day experiments (Supplementary Table S4 ). A B C D
Supplementary Figure S1. Comparison of GC-MS and GC-MS/MS
Stability tests
A stability test after three freeze and thaw cycles did not show statistically significant differences. There were also no significant differences found for a temperature stability test after leaving the sample for one day at room temperature, a 3-day post-preparative stability test for steroids after derivatization at room temperature, or for one-month stability test for the stock solutions of analytes.
Limit of Detection and Limit of Quantification
The lowest nonzero standard on the calibration curve defined the sensitivity. The analyte response at the LOQ was at least five times the analyte response of the zero calibrator and the bias at the LOQ was at most ±20% of nominal concentration (as found using replicates prepared in six different runs). Similarly, the imprecision was at most ±20% RSD as found using six replicates in four runs (2018) (see Table 3 ).
The LOD was sufficient in all cases where the intra-and/or inter assay for precision did not exceeded the 15% RSD (see Table 3 ) but the LOQ was borderline for the levels of AD3α5β17β and AD3α5β17β, E1 and PD3α5β17 levels in subjects out of pregnancy, and E2 and THP3α5α levels in men.
Specificity/selectivity of the method
In the co-eluting steroids, the selectivity was tested by injecting large amounts of the individual steroids and checking the potential contribution to other steroids respecting circulating levels of the potential interferents. For instance, for the transition 360>84 between DHEA and epiandrosterone we found some interference. On the other hand, the interference of DHEA for transition 360>270 in epiandrosterone was absent. Therefore, we choose the transition for quantitation of epiandrosterone 360>270 instead of the 360>84 transition. We also tested partly co-eluting pregnenolone and isopregnanolone and found some interference on 388>70 but no interference on 388>173 transition, which was then chosen for quantitation of isopregnanolone. The interferences were also tested for 388>70 transition between partly co-eluting 7β-OH-DHEA and allopregnanolone but there was no perceptible interference. Some interference was found for 421>255 transition between partly co-eluting 5-androstene-3β,17β-diol and 5α-androstane-3β,17β-diol but the corresponding peaks only marginally coincided and the quantitation was possible. Besides the cases mentioned above and DOF, Preg16α, T16α, in which only a single MRM transition was recorded, no further perceptible interferences were found and the remaining ion ratios were within the tolerance according to WADA Technical Document -TD2010IDCR "Identification Criteria for Qualitative Assays Incorporating Column Chromatography and Mass Spectrometry".
The levels of DOF were higher in male serum pool when compared with our previously published data from RIA assays (Hill et al. 1995) , possibly due to the unintentional inclusion of patients with Cushing syndrome or congenital adrenal hyperplasia in some pooled samples. However, the recording of a single MRM transition for DOF did not rule out the possibility of some endogenous co-eluting interference being responsible of the apparent larger concentrations.
Efficiency of methanolysis and stability of non-deuterated and deuterated steroids
The deconjugating step in the present method was performed using the methanolysis according to Dehennin . This harsh acid hydrolysis is an adopted method of deconjugation that efficiently and rapidly cleaves both sulfates and glucuronides simultaneously. However, the formation of artefactual byproducts is a known weakness of this method , Shackleton et al. 2004 , Viljanto et al. 2018 .
The results characterizing the efficiency of methanolysis for seven steroids sulfates/disulfates are summarized in in Supplementary Table S5 . The efficiency of the methanolysis step for individual steroid sulfates was high, ranging from 85% to 116% (98 ± 11%, shown as mean ± SD) (see Supplementary Table S5) . Furthermore, we have tested the methanolysis efficiency for the DHEA sulfate using the same protocol but sulfated D6-DHEA as the internal standard. The efficiency of methanolysis step was close to absolute and almost the same when using the unconjugated or sulfated D6-DHEA as the internal standard (102.6 ± 0.9%, shown as mean ± SD).
Considering the high efficiency of the methanolysis step, there is probably lessened necessity to use sulfated internal standards instead of the unconjugated ones as the deconjugation step does not represent a critical point in methanolysis. Thus, the more available unconjugated deuterated steroids may be used as satisfactory surrogates instead of their more appropriate conjugated equivalents. However, all internal standards (regardless their conjugation status) should possess isotopic stability in strongly acidic environment, which occurs during the methanolysis.
Some steroids, have also limited chemical stability during the methanolysis , Viljanto et al. 2018 . Dehennin et al. report, that while the sulfates of androsterone, epitestosterone, testosterone, 5-androstene-3β,17β-diol (5-Adiol) and DHEA and glucuronides of androsterone and testosterone are almost totally recovered using the methanolysis, steroids with tertiary alcohol in the steroid 17 position and secondary alcohol in the steroid 11β-position may dehydrate in strongly acidic conditions. This environment stimulates a protonation of the oxygen attached to steroid C-17 position and the nucleophilic attack by methanol, which consequently induces a cleavage of sulfate and glucuronide moieties on steroid molecules. However, there is also a risk of partial dehydration and formation of double bond (Viljanto et al. 2018) .
The analysis of steroid chemical stability of unconjugated steroids (see section 2.7.6.) showed that most of them were relatively stable during the methanolysis, however in a part of them the stability was low, particularly in 7α/β-hydroxy-metabolites of 5-Adiol. Similarly, estrogens, 16α -hydroxy-metabolite of 5-Adiol and 11β-hydroxyand 3-oxo-steroids showed a limited stability (Supplementary Table S6 ). Nevertheless, even in these cases, one can expect a similar degree of conversion to artefacts in standard and unknown samples on condition that they are processed in the same way in one run. So, the obtained results may be still acceptable as apparent in tables presenting analytical criteria for conjugated forms of these analytes (see section 3.1.). We are aware that the use of chemically and isotopically stable deuterated external standards with sufficient isotopic purity in conjugated forms would be a by far better approach.
The accessibility of appropriate deuterated conjugated internal standards is even more critical. Moreover, the deuterated internal standards are often isotopically unstable. The strongly acidic environment during the methanolysis promote deuterium-hydrogen exchange, which considerably limits the number of applicable deuterated standards. For instance, a complete deuterium-hydrogen exchange was observed in a deuteriumlabelled, D9-progesterone during methanolysis but no change was observed when the samples spiked with D9-progesterone were incubated with methanol in the neutral environment. The deuterium-hydrogen exchange is induced by acid-catalyzed enol tautomer formation when the double bond rapidly moves between the keto and enol forms. Although the equilibrium usually favors the keto-tautomer, it can be shifted to the enol-one by acidic or alkaline environment. Steroids labelled on an α-carbon adjacent to a ketone functional group(s) exhibit the hydrogen exchange, whereas other labelled analytes are unlikely to cause any problems. In extreme situations, such as in the case of D9-progesterone, the deuterium-hydrogen exchange via keto-enol tautomerism may lead to the formation of unlabeled product (Viljanto et al. 2018) . We observed this effect during the methanolysis when using D9-progesterone and D8-17α-hydroxyprogesterone as internal standards. Besides the problems with the isotopic stability, the relatively frequent drawback of deuterated internal standards may be also their insufficient isotopic purity, which is specifically critical in analytes showing wide biological variability such as pregnane steroids exhibiting extreme changes during the menstrual cycle and pregnancy.
In contrast to some authors discriminating between glucuronide, monosulfate and disulfate moieties on steroid molecules, we did not test their levels separately (Mareck et al. 2008 , Meng et al. 1997 ) but measured only the total polar conjugates. On one hand, the concurrent deconjugation of sulfates and glucuronides is a weakness of our method but on the other hand, the methanolysis is more robust and less laborious then the enzymatic hydrolysis or microcolumn pre-separation of sulfate, disulfate or glucuronide moieties from each other. Nevertheless, the discrimination between these moieties may be desirable in the diagnostics of some disorders such as the intrahepatic cholestasis of pregnancy. In this pathology, from a variety of pregnanediols, only the of 5α-pregnane-3α,20α-diol disulfate is considered as toxic for fetus (Abu-Hayyeh et al. 2013 , Meng et al. 1997 ).
Supplementary Table S1.
Comparison of results from GC-MS and GC-MS/MS using Passing-Bablok regression and Bland-Altman procedure (1 pooled serum sample from non-pregnant subjects, and sera from 4 adult men, 4 women in follicular phase, 4 women in luteal phase, 4 women at labor, and 4 samples from mixed umbilical blood at labor were analyzed). 
Steroid
correlation coefficient between results from GC-MS and GC-MS/MS. M, F, L, P, and U represent inclusion of samples from men, women in luteal phase, women in follicular phase, pregnant women and umbilical cord blood, respectively.
Supplementary Table S1, continued. Comparison of results from GC-MS and GC-MS/MS using Passing-Bablok regression and Bland-Altman procedure (1 pooled serum sample from nonpregnant subjects, and sera from 4 adult men, 4 women in follicular phase, 4 women in luteal phase, 4 women at labor, and 4 samples from mixed umbilical blood at labor were analyzed). 0.04 0.5(-9.9%,10%) 
Steroid
. Symbol r represent a correlation coefficient between results from LC-MS/MS (RIA) and GC-MS/MS.
--- --- --- --- --- --- 130/20 1.1/7.1 180/29 1.4/7.4 30 THP3β5β 0.03 0.1(14%,6.9%) --- --- --- --- --- --- 8) --- --- --- --- --- --- 3700/680 9.4/9 200/37 0.42/3.4 71 E2C 0.2 2(3.5%,8.7%) --- --- --- --- --- --- 160/29 1.1/14 29/5.3 7.2/10 72 E3C 0.6 8(3.9%,9.4%) --- --- --- --- --- --- 3300
Comparison of the present GC-MS/MS method with our previous GC-MS method
Due to the high number of analytes and variety of steroids measured in human circulation, a comparison of all steroids with results from other methods was unachievable. Nevertheless, a number of our present results are comparable with those data from our previously published GC-MS method (Bicikova et al. 2013 , Hill et al. 2010b , Hill et al. 2011a , Hill et al. 2011b , Hill et al. 2010c , Kancheva et al. 2011 , Majewska et al. 2014 , Parizek et al. 2016 , Vankova et al. 2016 ) as well as with the results of other authors (see citations in (Hill et al. 2010b) ).
The agreement between GC-MS, LC-MS/MS, RIA (for cortisol) and our present method for individual analytes mostly ranged from satisfactory to excellent results (Supplementary Table S1 and Supplementary Table S2 , Supplementary Figure S1 and Supplementary Figure S2 ,) even if there were little deviations from identity line and problems with LDR in two analytes. We compared responses to samples injected in high-(2 μL) and low injection volumes (0.2 μL) for analytes with high circulating levels (some conjugated steroids) and found two of them, in which a considerable number of responses was not proportional to the injected volume (DHEA sulfate and androsterone sulfate). In these analytes, the samples from subjects with lower analyte circulating levels showed tight correlations between concentrations calculated from low-and high injection volume and slopes (using the same calibration curve) of the corresponding regression lines did not significantly differ from 1. However, in the samples from subjects with higher analyte concentrations, the divergence between concentrations calculated for samples injected at high and low injection volume began to grow. Here the samples injected in low volume showed higher concentrations when compared with the same ones injected in the high volume (see Supplementary Figure S3 ). It is evident that samples from subjects with higher analyte circulating levels underwent the same treatment as those from subject with the lower analyte circulating levels. Thus, the only cause of the differences in the former group should be the different injection volumes. As expected, the only change at lower injection volume was the shift of the analyte response to LDR in the samples from subjects with higher analyte circulating levels without significant influence on results in the samples from subject with the lower analyte circulating levels. These levels evidently remained sufficiently high for analysis at lower injection volumes. Based on these data, the sulfates of DHEA and androsterone were measured at low injection volumes of samples in the present method and the method validation for these steroid conjugated was also completed at low injection volumes.
In addition to the steroids quantified in the previous method (Hill et al. 2010b ), the present one was extended for corticoids, 11β-hydroxy-androstanes and 17α-hydroxylated 5α/β-reduced pregnanes. The last-mentioned substances may be useful for the investigation of the alternative "backdoor" pathway. When comparing the analytical characteristics of the present and previous methods, the first exhibited by far higher selectivity, generally higher sensitivity and better precision particularly for 17α-hydroxysteroids. However, in the case of estrogens the precision was worse and even unsatisfactory for estrone in non-pregnant subjects, which may be associated with the use of different derivatization agent in the silylation step and worse repeatability (during the drying of derivatized mixture under nitrogen because to its higher heterogeneity in comparison with our previous method). On the other hand, the more intense and lengthier derivatization together with the use of more advanced GC-MS/MS platform resulted in substantially improved sensitivity and precision in 17α-hydroxysteroids and enabled the quantification of corticoids and 11β-hydroxy-androgens, which were undetectable by our previous method.
Limitations of our method
We acknowledge that our proposed method has some limitations. The first is the absence of conjugated external and deuterated internal standards in most conjugated steroids and absence of deuterated internal standards even for most unconjugated steroids. The first reason was a limited accessibility of these substances. The further serious problem especially in quantification of conjugated steroids was chemical and isotopic instability as well as isotopic impurity of various deuterated standards (as discussed above). Therefore, we excluded the analysis of four steroid conjugates, which were well detectable but extremely instable during the hydrolysis such as conjugated 7α/β-hydroxy-metabolites of DHEA and 5-Adiol. The difficult accessibility, isotopic and chemical instability were also the reasons for which we used only a single (but pure and stable) deuterated steroid conjugate (D6-DHEA sulfate) as the internal standard for the quantification of conjugated steroids.
Furthermore, in spite of wide spectrum of the measured steroids some diagnostically important steroids remained, which were not included. Partly due to unfavorable fragmentation pattern of the steroid even after derivatization resulting in low sensitivity as in the case of 11-deoxycortisol. In addition, 11-deoxycorticosterone was below the LOQ for non-pregnant subjects and 21-deoxycortisol was above the LOQ for all groups but the sensitivity was also relatively low. Also, the sensitivity for estrogens in non-pregnant subjects was low. The quantification of interesting steroids such as 11β-hydroxy-testosterone, 11-oxo-testosterone and 11-oxoandrostenedione was not tested as well as the measurement of steroid 6α/β-hydroxy-catabolites.
Conclusions
To the best of our knowledge, in spite of the limitations described above, this is the first GC-MS/MS method for multicomponent quantitation of circulating steroids validated for different physiological conditions in humans including gender differences and pregnancy status. In addition, this method currently includes the largest spectrum of human circulating steroids and steroid polar conjugates, at least for the GC-MS/MS platform. As have been demonstrated in our previous papers, steroid profiling enables various pathologies to be rapidly diagnosed (Bicikova et al. 2013 , Hill et al. 2010c , Kanceva et al. 2015 , Parizek et al. 2016 , Sosvorova et al. 2015 , Vankova et al. 2016 ). The present GC-MS/MS method includes a wide range of analytes, which reflect activities of most steroidogenic enzymes. Thus, it could be used for the estimation of changes in steroidogenesis for various physiological and pathophysiological situations and subsequently the data obtained can be utilized for uncovering the mechanisms of some steroid-related human pathologies (Parizek et al. 2016 , Sterzl et al. 2017 , Vankova et al. 2016 . Nevertheless, the hydrolysis step is laborious and may carry problems with stability of some steroid conjugates. Furthermore, some positions of sulfate or glucuronide groups in steroid molecule may be resistant to hydrolysis although the deconjugation step used in the present method appears to be quite efficient. Moreover, the physiological and pathophysiological importance of steroid sulfates and glucuronides may be different. Therefore, the future work in steroid assay development should strive to measure the entire conjugated molecule without hydrolysis.
